RPTX•benzinga•
Reported Earlier, Repare Therapeutics Focuses On RP-1664 And RP-3467, Seeks Partners For Lunre+Camo, And Reports $153M Cash On Hand
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 10, 2025 by benzinga